Spyre Therapeutics, Inc.SYRE
Close of Friday, October 23, 2026 · Spyre Therapeutics, Inc. is trading above its Pivot, OnlyAlpha's long-term trend line.
Price
$90.32
vs its Pivot
+26.2%
OnlyAlpha Score
47
Trend
Above its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| +3.7% | +175.7% | +306.7% | — | — |
No dividend in the last 12 months.
Who runs and owns it
In these funds
IBB · 0.51%IWM · 0.23%
Big investors that own it (latest 13F)
| Perceptive Advisors | 6.0% of holdings |
| OrbiMed | 0.3% of holdings |
Get SYRE in your free daily emailAfter every close: whether SYRE is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track SYRE free → Full Stock check
Track SYRE free → Full Stock check